Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia
Clinical trial NCT02157324 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02157324
- Sponsor
- Acerta Pharma BV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-18
- Primary completion
- 2020-07-20
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.